Financial Advisors Network, Inc. Nektar Therapeutics Transaction History

Financial Advisors Network, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$14.47 - $27.96 $654,405 - $1.26 Million	-45,225 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$15.87 - $23.12 $80,857 - $117,796	5,095 Added 12.7%	45,225 $976,000
Q3 2019 Nov 12, 2019	BUY	$16.91 - $36.27 $127,636 - $273,765	7,548 Added 23.17%	40,130 $731,000
Q2 2019 Aug 09, 2019	BUY	$31.0 - $36.3 $97,774 - $114,490	3,154 Added 10.72%	32,582 $938,000
Q1 2019 Jun 04, 2019	BUY	$31.58 - $46.35 $929,336 - $1.36 Million	29,428 New	29,428 $922,000

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Financial Advisors Network, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Advisors Network, Inc. with notifications on news.